388 related articles for article (PubMed ID: 17629428)
1. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
Beránková K; Szkutová M; Balíková M
Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
[TBL] [Abstract][Full Text] [Related]
2. Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration.
Rohanova M; Balikova M
Toxicology; 2009 May; 259(1-2):61-8. PubMed ID: 19428944
[TBL] [Abstract][Full Text] [Related]
3. Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats.
Jiang SZ; Wang NS; Mi SQ
Biopharm Drug Dispos; 2008 Dec; 29(9):529-37. PubMed ID: 19051331
[TBL] [Abstract][Full Text] [Related]
4. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
Brunet B; Doucet C; Venisse N; Hauet T; Hébrard W; Papet Y; Mauco G; Mura P
Forensic Sci Int; 2006 Sep; 161(2-3):169-74. PubMed ID: 16859848
[TBL] [Abstract][Full Text] [Related]
5. Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration.
Rohanová M; Pálenícek T; Balíková M
Toxicol Lett; 2008 Apr; 178(1):29-36. PubMed ID: 18339493
[TBL] [Abstract][Full Text] [Related]
6. Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose.
Balíková M
Forensic Sci Int; 2005 Oct; 153(1):85-91. PubMed ID: 15979834
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
Shimamine M; Takahashi K; Nakahara Y
Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
[TBL] [Abstract][Full Text] [Related]
9. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Ewald AH; Fritschi G; Bork WR; Maurer HH
J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
[TBL] [Abstract][Full Text] [Related]
10. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
[TBL] [Abstract][Full Text] [Related]
11. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
[TBL] [Abstract][Full Text] [Related]
12. Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats.
Aravagiri M; Marder SR
Psychopharmacology (Berl); 2002 Feb; 159(4):424-31. PubMed ID: 11823895
[TBL] [Abstract][Full Text] [Related]
13. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
14. Studies on distribution of para-methoxymethamphetamine (PMMA) designer drug in rats using gas chromatography-mass spectrometry.
Rohanova M; Balikova M
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S429-30. PubMed ID: 19261515
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
Deneke J; Luckow V; Guserle R; Pässler HH
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone.
Helton DR; Osborne DW; Pierson SK; Buonarati MH; Bethem RA
Drug Metab Dispos; 2000 Aug; 28(8):925-9. PubMed ID: 10901702
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats.
Myers SR; Spinnato JA
Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234
[TBL] [Abstract][Full Text] [Related]
19. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
Gómez-Martínez LE
Int J Toxicol; 2007; 26(3):237-46. PubMed ID: 17564905
[TBL] [Abstract][Full Text] [Related]
20. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]